Understanding Krystexxa (Pegloticase) Side Effects: What Gout Patients Need to Know

Krystexxa (generic name: pegloticase) is a powerful intravenous medication used to treat chronic gout in adults who haven't responded well to other treatments. While it can be highly effective at lowering uric acid levels, it's important for patients to understand the potential side effects before starting treatment.

What is Krystexxa?

Krystexxa is a biologic medication administered by intravenous infusion, typically every two weeks. It works by converting uric acid into allantoin, a substance that the body can easily eliminate. For patients with severe, treatment-resistant gout, Krystexxa can be a game-changer—but it comes with significant considerations.

Critical Safety Warning: Anaphylaxis and Infusion Reactions

The most serious risks associated with Krystexxa are anaphylaxis and infusion reactions. These can occur during or after administration:

• Anaphylaxis (reported in 4.8-6.5% of patients) is a severe, life-threatening allergic reaction that typically manifests within 2 hours of infusion
• Infusion reactions occur in 26-41% of patients, depending on dosing frequency

Krystexxa must be administered in healthcare settings by providers prepared to manage these emergencies. Patients should be premedicated with antihistamines and corticosteroids, and monitored closely after each infusion.

Signs of Anaphylaxis to Watch For:

• Rash, hives, or itching
• Dizziness or fainting
• Swelling of face, lips, tongue, or throat
• Difficulty breathing or swallowing
• Chest pain or tightness
• Fast heartbeat

If you experience any of these symptoms during or after treatment, seek emergency medical attention immediately.

Common Side Effects (Occurring in 10% or More of Patients)

Gout Flares (77% of patients)

Paradoxically, gout flares are the most common side effect when starting Krystexxa. This happens because rapidly falling uric acid levels cause urate crystals to mobilize from tissue deposits. Important: Do not stop treatment if you experience a gout flare—your doctor can provide medications like colchicine or NSAIDs to manage symptoms.

Infusion Reactions (26-41%)

Symptoms include:

• Urticaria (hives)
• Difficulty breathing
• Chest discomfort or pain
• Skin redness (erythema)
• Itching (pruritus)

Nausea (12%)

Gastrointestinal upset is relatively common but usually manageable.

Skin Reactions

• Contusions/bruising (11%) – often related to other factors like diabetes or blood thinners
• Ecchymosis (11%) – larger discolored patches on the skin
• Urticaria (10.8%) – hives or welts

Immunologic Response

Up to 92% of patients develop antibodies to pegloticase. Your doctor will monitor serum uric acid levels before each infusion—if levels rise above 6 mg/dL on two consecutive tests, treatment should be discontinued.

Less Common Side Effects (1-10% of Patients)

• Constipation
• Vomiting
• Erythema (skin redness)
• Pruritus (itching)
• Dyspnea (shortness of breath)
• Nasopharyngitis (cold-like symptoms)
• Chest discomfort or pain

Rare but Serious Side Effects

• Decreased urine output
• Extreme fatigue
• Irregular heartbeat
• Swelling of face, fingers, feet, or legs
• Unexplained weight gain
• Congestive heart failure exacerbation

Critical Precaution: G6PD Deficiency

Krystexxa is contraindicated in patients with G6PD deficiency (glucose-6-phosphate dehydrogenase deficiency). This genetic condition is more common in patients of African, Mediterranean, or Southern Asian ancestry. In these patients, Krystexxa can cause:

• Life-threatening hemolysis (destruction of red blood cells)
• Methemoglobinemia (a dangerous blood disorder)

All patients must be screened for G6PD deficiency before starting treatment.

What You Can Do

1. Ensure proper monitoring: Only receive Krystexxa in certified healthcare facilities equipped to handle emergencies
2. Stay for observation: Don't leave immediately after your infusion
3. Report symptoms promptly: Tell your nurse or doctor immediately if you feel unwell during treatment
4. Don't skip premedications: The antihistamines and corticosteroids given before infusion significantly reduce reaction risk
5. Continue gout flare prophylaxis: Take prescribed colchicine or NSAIDs as directed, especially in the first 3 months
6. Keep all appointments: Regular blood tests are essential to monitor your response and detect antibody formation

The Bottom Line

Krystexxa can be life-changing for patients with severe, refractory gout—but it's not a casual medication. The risk of serious allergic reactions requires careful administration in medical settings, and the high incidence of infusion reactions means patients need to be vigilant.

If you and your doctor determine that Krystexxa is right for you, work closely with your healthcare team, understand the warning signs, and never skip the monitoring appointments. For the right patient under proper medical supervision, the benefits often outweigh the risks.

---

Sources:

1. Drugs.com. "Krystexxa Side Effects." Medically reviewed, last updated July 9, 2025. https://www.drugs.com/sfx/krystexxa-side-effects.html

2. Savient Pharmaceuticals. "Product Information. Krystexxa (pegloticase)." 2010.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider about your specific situation.